Mer Antibody (Rabbit mAb) [C10E14]

Catalog No.: F1198

    Application: Reactivity:
    • Lane 1: 293T
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    SDS-PAGE の分離ゲルの推奨濃度:5%

    使用情報

    Dilution
    1:2000
    1:20
    1:1000-1:2000
    Application
    WB, IP, IHC
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    110 kDa 140-180 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Human tonsil tissue; Human lymphoma tissue; Human spleen tissue; HEK-293 cells; A549 cells; HAP1 cells; A172 cells; K562 cells
    ネガティブコントロール CV1 cells

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Add protein loading buffer to the 20 μL sample, and keep it on ice for immediate use; or determine the optimal denaturation conditions by boiling the sample at a temperature gradient (e.g., 37°C, 50°C, 70°C, 90°C, and 100°C). Cool the sample on ice and centrifuge for 5 min.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:2000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IHC
    Experimental Protocol:
     
    Deparaffinization/Rehydration
    1. Deparaffinize/hydrate sections:
    2. Incubate sections in three washes of xylene for 5 min each.
    3. Incubate sections in two washes of 100% ethanol for 10 min each.
    4. Incubate sections in two washes of 95% ethanol for 10 min each.
    5. Wash sections two times in dH2O for 5 min each.
    6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
     
    Staining
    1. Wash sections in dH2O three times for 5 min each.
    2. Incubate sections in 3% hydrogen peroxide for 10 min.
    3. Wash sections in dH2O two times for 5 min each.
    4. Wash sections in wash buffer for 5 min.
    5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
    6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
    7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
    8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
    9. Wash sections three times with wash buffer for 5 min each.
    10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
    11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
    12. Immerse slides in dH2O.
    13. If desired, counterstain sections with hematoxylin.
    14. Wash sections in dH2O two times for 5 min each.
    15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
    16. Mount sections with coverslips and mounting medium.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    Mer Antibody (Rabbit mAb) [C10E14] detects endogenous levels of total Mer protein.
    タンパク質の局在
    細胞膜、細胞内膜系
    Uniprot ID
    Q12866
    Clone
    C10E14
    Synonym(s)
    MER, MERTK, Tyrosine-protein kinase Mer, Proto-oncogene c-Mer, Receptor tyrosine kinase MerTK
    Background
    Mer (MERTK) is a transmembrane receptor tyrosine kinase of the TAM family, together with AXL and TYRO3, and functions as a surface receptor that controls apoptotic cell clearance, immune homeostasis, and tissue integrity in systems such as the retina and mononuclear phagocyte compartment. The receptor contains an extracellular region with tandem immunoglobulin‑like and fibronectin type III domains that bind vitamin K–dependent ligands, a single transmembrane segment, and a cytoplasmic tyrosine kinase domain with multiple regulatory tyrosines that undergo autophosphorylation after ligand engagement. Gas6 and Protein S are physiological ligands that bind Mer via their laminin G–like domains while their N‑terminal Gla regions contact phosphatidylserine on apoptotic cell membranes; this configuration presents apoptotic targets to Mer‑expressing phagocytes and positions the kinase domain for activation. Ligand‑dependent Mer activation induces autophosphorylation on intracellular tyrosines and creates docking sites for SH2‑containing adaptors such as GRB2, GAB1, and PI3K regulatory subunits, which connect Mer to RAS/RAF/MEK/ERK and PI3K/Akt signaling modules that promote cytoskeletal remodeling, engulfment cup formation, and survival of the phagocytic cell during efferocytosis. Mer signaling also upregulates suppressor of cytokine signaling proteins and other negative regulators of innate immunity, which limit pro‑inflammatory cytokine production during apoptotic cell clearance and maintain a non‑immunogenic environment in tissues engaged in high‑volume efferocytosis such as the retinal pigment epithelium. Retinal pigment epithelial cells express Mer and perform circadian phagocytosis of shed photoreceptor outer segments, and Gas6 and Protein S cooperate to control rhythmic Mer activation, with differential binding to distinct residues in Mer Ig‑like domains and time‑dependent changes in ligand availability contributing to daily peaks of photoreceptor outer‑segment ingestion that are essential for long‑term visual function. Macrophages and dendritic cells express Mer together with AXL and TYRO3, and Mer‑dependent efferocytosis of apoptotic cells exposed to phosphatidylserine contributes to resolution‑phase programming and modulation of macrophage polarization, with TAM signaling showing a characteristic association with anti‑inflammatory and tissue‑repair phenotypes. MERTK upregulation or ectopic expression in diverse epithelial and hematologic malignancies, where Mer activation by Gas6, Protein S, or other ligands such as Tubby, Tulp1, and Galectin‑3 induces receptor autophosphorylation and stimulates downstream PI3K/Akt, MAPK, and STAT signaling pathways that support survival, proliferation, chemoresistance, and motility of tumor cells, and Mer‑driven efferocytosis by tumor or stromal cells correlates with PD‑L1 induction and immune evasion.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください